Malaysian Genomics Resource Centre Bhd (XKLS:0155) Total Liabilities : RM4.68 Mil (As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Total Liabilities?

Malaysian Genomics Resource Centre Bhd's Total Liabilities for the quarter that ended in Jun. 2024 was RM4.68 Mil.

Malaysian Genomics Resource Centre Bhd's quarterly Total Liabilities declined from Sep. 2023 (RM4.16 Mil) to Mar. 2024 (RM4.09 Mil) but then increased from Mar. 2024 (RM4.09 Mil) to Jun. 2024 (RM4.68 Mil).

Malaysian Genomics Resource Centre Bhd's annual Total Liabilities declined from Jun. 2019 (RM21.07 Mil) to Jun. 2020 (RM0.00 Mil) but then increased from Jun. 2020 (RM0.00 Mil) to Jun. 2021 (RM4.85 Mil).

Malaysian Genomics Resource Centre Bhd Total Liabilities Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Total Liabilities Chart

Malaysian Genomics Resource Centre Bhd Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Total Liabilities

Get a 7-Day Free Trial

13.49

21.07

4.85

Malaysian Genomics Resource Centre Bhd Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Mar24	Jun24
Total Liabilities	Get a 7-Day Free Trial															2.62	2.84	4.16	4.09	4.68

Malaysian Genomics Resource Centre Bhd Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Malaysian Genomics Resource Centre Bhd's Total Liabilities for the fiscal year that ended in Jun. 2021 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.551	+	(1.302	+	-4.4408920985006E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	4.85

Total Liabilities	=	Total Assets (A: Jun. 2021 )	-	Total Equity (A: Jun. 2021 )
	=	22.783	-	17.93
	=	4.85

Malaysian Genomics Resource Centre Bhd's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.262	+	(1.42	+	4.4408920985006E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	4.68

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	23.862	-	19.18
	=	4.68

Malaysian Genomics Resource Centre Bhd Total Liabilities Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Malaysian Genomics Resource Centre Bhd Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810

Website

http://www.mgrc.com.my

Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd Headlines

No Headlines